Similarly, Vici et al. reported that while YAP or TAZ alone did not impact pathological response, the combined expression of YAP in both tumor and stromal compartments was independently associated with decreased likelihood of achieving pCR (OR: 7.13, p = 0.029) and shorter disease-free survival (HR: 3.07, p = 0.016) in TNBC patients [30]. This evidence concerns the gene YAP1 and neoplasm.